Improvement of sleep and melatonin in children with autism spectrum disorder after β‐1,3/1,6‐glucan consumption: An open‐label prospective pilot clinical study

INTRODUCTION: Poor sleep quality is a major problem in patients with autism spectrum disorder (ASD), and is attributed to low melatonin levels. Melatonin supplementation is recommended; however, its effectiveness varies. β‐Glucans have previously been shown to improve melatonin levels in animal stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghavan, Kadalraja, Dedeepiya, Vidyasagar Devaprasad, Kandaswamy, Ramesh Shankar, Balamurugan, Mangaleswaran, Ikewaki, Nobunao, Sonoda, Tohru, Kurosawa, Gene, Iwasaki, Masaru, Preethy, Senthilkumar, Abraham, Samuel JK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480952/
https://www.ncbi.nlm.nih.gov/pubmed/35993920
http://dx.doi.org/10.1002/brb3.2750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480952/
https://www.ncbi.nlm.nih.gov/pubmed/35993920
http://dx.doi.org/10.1002/brb3.2750

Ejemplares similares